Insider Selling: Outset Medical, Inc. (NASDAQ:OM) SVP Sells 23,221 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 23,221 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total value of $18,576.80. Following the sale, the senior vice president now owns 204,968 shares in the company, valued at approximately $163,974.40. The trade was a 10.18 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Marc Nash also recently made the following trade(s):

• On Monday, January 13th, Marc Nash sold 15,011 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total value of $12,158.91.
• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Stock Up 10.3 %

Shares of NASDAQ:OM opened at $0.86 on Friday. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49. Outset Medical, Inc. has a 52-week low of $0.44 and a 52-week high of $5.22. The business’s 50 day simple moving average is $1.01 and its two-hundred day simple moving average is $1.28. The firm has a market cap of $45.18 million, a P/E ratio of -0.31 and a beta of 2.05.

Analysts Set New Price Targets

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.

Hedge Funds Weigh In On Outset Medical

A number of institutional investors have recently modified their holdings of OM. Vanguard Personalized Indexing Management LLC bought a new stake in Outset Medical during the 2nd quarter valued at $49,000. National Bank of Canada FI grew its holdings in shares of Outset Medical by 79.2% during the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after buying an additional 23,164 shares during the last quarter. Huntington National Bank increased its position in shares of Outset Medical by 46.2% during the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after acquiring an additional 20,000 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Outset Medical in the 2nd quarter worth about $259,000. Finally, Squarepoint Ops LLC lifted its position in Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after acquiring an additional 34,187 shares in the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.